1,640 results on '"Thiede, Christian"'
Search Results
2. Recommendations from the AML molecular MRD expert advisory board
3. Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
4. Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence
5. VEXAS syndrome: complete molecular remission after hypomethylating therapy
6. Prognostic impact of CEBPA mutational subgroups in adult AML
7. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
8. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
9. Activation of distinct inflammatory pathways in subgroups of LR-MDS
10. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
11. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
12. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
13. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
14. Klonale Hämatopoese – Bedeutung für die Zelltherapie
15. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
16. Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
17. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
18. Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs
19. Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO
20. Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia
21. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
22. Overlapping features of therapy-related and de novo NPM1-mutated AML
23. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients
24. Pathogenese und molekulare Diagnostik der akuten myeloischen Leukämie
25. Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML
26. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
27. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
28. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
29. Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes
30. Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment
31. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
32. Lipidomic approach for stratification of Acute Myeloid Leukemia patients
33. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
34. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears
35. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
36. Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns
37. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
38. Clonal hematopoiesis and its emerging effects on cellular therapies
39. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
40. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
41. Prognostic impact of CEBPA mutational subgroups in adult AML
42. Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma
43. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
44. VEXAS Syndrome: Complete molecular remission after hypomethylating therapy
45. Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence
46. The clinical mutatome of core binding factor leukemia
47. Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
48. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
49. Characterization of acute myeloid leukemia with del(9q) – Impact of the genes in the minimally deleted region
50. Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.